Monitoring of HIV-Spread in Regional Populations of Injecting Drug Users — the Berlin Experience

  • F. Bschor
  • R. Bornemann
  • CH. Borowski
  • V. Schneider


The epidemiological WHO-data for AIDS show, as we all know, that the increase of AIDS cases from the group of intravenous drug users (IVDU) is higher than in the other risk groups, and has reached a total of about one third of all cumulative reported AIDS cases in Europe (4). The vertical Virus transfer to the next generation is mainly caused by infected mothers from the group of drug users or by mothers with sexual contact to drug users. Regarding the horizontal virus transfer from the population at risk to the general population in the pattern-1-countries there is little doubt that the IVDU population is of great importance (3,7,13).


Drug User Inject Drug User Intravenous Drug User Death Case Virus Transfer 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1).
    Bornemann R, Bschor F, Platz W, Rex R, Püschel K, Schneider V (1990) Rückgang der HIV-1-Prävalenz bei i.v.-Drogenabhängigen in Berlin W and Hamburg: Erfolg der Prävention? 3. Deutscher AIDS-Kongreß Hamburg 24.-27. 11. 1990Google Scholar
  2. 2).
    Bschor F, Schneider V, Bornemann R, Püschel K (1988) Dynamics of HIV-spread amongst iv-drug addicts. Proceedings of the 35th International Congress on Alcoholism and Drug Dependence. Oslo Vol 1: 378–386Google Scholar
  3. 3).
    Des Jarlais DC, Friedman SR, Stoneburger RL (1988) HIV Infection and Intravenous Drug Use: Critical Issues in Transmission Dynamics, Infection Outcomes, and Prevention. Reviews of Infectious Diseases 10: 151–158Google Scholar
  4. 4).
    European Centre for the Epidemiological Monitoring of AIDS. AIDS Surveillance in Europe. Quarterly Report Nr 28 from 31st Dec 1990Google Scholar
  5. 5).
    Kaldor J (1990) Review of Australian HIV Seroprevalence Studies among Intravenous Drug Users (IVDU) DRAFT National Centre in HIV Epidemiology and Clin. Research, Faculty of Medicine, The University of New South WalesGoogle Scholar
  6. 6).
    Kleiber D (1991) Drug Addiction and AIDS in Germany. First European Symposium on Drug Addiction and AIDS, Vienna Feb 21–23 1991Google Scholar
  7. 7).
    Mersey Regional Health Authority Drugs and HIV Monitoring Unit (1990) HIV infection among drug injectors in England. Internat. J. Drug Policy I /4: 15–15Google Scholar
  8. 8).
    Newcombe R (1989) Preventing the spread of HIV infection. Internat.J Drug Policy I /2: 20–27Google Scholar
  9. 9).
    Puschel K, Lieske K, Laufs R, Bschor F, Schneider V, Marcus U (1988) Entwicklung der HIV-1-Antikörperprävalenz bei Rauschgifttoten in Berlin und Hamburg. AIFO 3: 452–454Google Scholar
  10. 10).
    Puschel K, Mohsenian F, Bornemann R, Bschor F, Schneider V, Penning R, Spann W, von Karger J, Madea B, Metter D: HIV-1-Prävalenz bei Drogentoten in verschiedenen Großstädten der Bundesrepublik Deutschland und in Westberlin zwischen 1985 und 1988. Z Rechtsmed 103: 407–414Google Scholar
  11. 11).
    Robertson JR, Bucknall ABV, Welsby PD, Roberts JJK, Inglis JM, Peutherer JF, Brettle RP (1986) Epidemic of AIDS related virus infection among intravenous drug users. Br Med J 292: 527–529CrossRefGoogle Scholar
  12. 12).
    Rosenbrock R (1986) AIDS kann schneller besiegt werden. Gesundheitspolitik am Beispiel einer Infektionskrankheit. VSA Verlag HamburgGoogle Scholar
  13. 13).
    Velimirowicz B (1987) AIDS und Drogenabhängigkeit aus der Sicht des Epidemiologen. AIFO 2: 323–334Google Scholar

Copyright information

© Springer-Verlag/Wien 1991

Authors and Affiliations

  • F. Bschor
    • 1
  • R. Bornemann
    • 2
  • CH. Borowski
    • 3
  • V. Schneider
    • 1
  1. 1.Institut für RechtsmedizinFreien Universität BerlinBerlin 33Federal Republic of Germany
  2. 2.I. Medizinische KlinikKrankenanstalten Bielefeld MitteFederal Republic of Germany
  3. 3.General PractionerCharlottenburgFederal Republic of Germany

Personalised recommendations